欢迎您访问《中华养生保健》官方网站!

中华养生保健 ›› 2023, Vol. 41 ›› Issue (15): 41-45.

• 临床研究 • 上一篇    下一篇

阿奇霉素及丙氧鸟苷雾化吸入治疗小儿支气管肺炎疗效及炎症因子影响

孙百弟   

  1. 山东省烟台市北海医院儿科,山东 烟台,265701
  • 出版日期:2023-08-01 发布日期:2023-08-03
  • 作者简介:孙百弟(1976—),男,汉族,籍贯:山东省烟台市,本科,副主任医师,研究方向:小儿呼吸、消化。

Effect of Aerosol Inhalation of Azithromycin and Guanosine Propionate on Children with Bronchopneumonia and Influence of Inflammatory Factors

SUN Bai-di   

  1. Department of Pediatrics, Yantai Beihai Hospital, Yantai Shandong 265701, China
  • Online:2023-08-01 Published:2023-08-03

摘要: 目的 探讨阿奇霉素及丙氧鸟苷雾化吸入治疗方法对支气管肺炎患儿的临床疗效以及对炎症因子水平的影响。方法 选取2021年8月—2022年8月山东省烟台市北海医院收治的支气管肺炎患儿84例作为研究对象,根据抛币法将患儿随机分为对照组和研究组,每组42例。对照组接受丙氧鸟苷雾化吸入治疗,研究组接受阿奇霉素联合丙氧鸟苷雾化吸入治疗,比较两组临床症状消失时间、住院时间、治疗总有效率、炎症因子[肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)]水平、肺功能[用力肺活量(FVC)、第一秒用力呼气量(FEV1)、FEV1/FVC]。结果 研究组患儿咳嗽缓解时间、发热消失时间、气促消失时间以及住院时间均短于对照组,差异有统计学意义(P<0.05)。研究组患儿治疗总有效率高于对照组,差异有统计学意义(P<0.05)。治疗前,两组TNF-α、IL-1β水平比较,差异无统计学意义(P>0.05);治疗后,两组TNF-α、IL-1β水平均降低,且研究组低于对照组,差异有统计学意义(P<0.05)。治疗前,两组FVC、FEV1、FEV1/FVC水平比较,差异无统计学意义(P>0.05);治疗后,两组FVC、FEV1、FEV1/FVC水平均升高,且研究组高于对照组,差异有统计学意义(P<0.05)。结论 支气管肺炎患儿通过阿奇霉素与丙氧鸟苷雾化吸入联合治疗,疗效确切,可明显缩短临床症状改善时间,减轻机体炎性反应,改善肺功能,值得临床使用。

关键词: 阿奇霉素, 丙氧鸟苷, 小儿支气管肺炎, 疗效, 炎症因子

Abstract: Objective To investigate the clinical efficacy of azithromycin and propoxyguanosine aerosol inhalation in children with bronchopneumonia and the effect on the level of inflammatory factors. Methods A total of 84 children with bronchopneumonia admitted to the pediatrics department of Yantai Beihai Hospital from August 2021 to August 2022 were selected as the subjects of this study. The children were randomly divided into control group and study group according to coin toss method. Among them, 42 cases in the control group received atomized inhalation therapy of propioguanosine, and 42 cases in the study group. Azithromycin combined with propoxyguanosine atomized inhalation therapy, the duration of clinical symptom disappearance, length of hospital stay, total response rate, levels of inflammatory factors (TNF-α, interleukin-1β), lung function [(forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), and ratio of forced expiratory volume in the first second to forced vital capacity (FEV1/FVC) were compared between the two groups )]. Results The duration of cough relief, fever disappearance, shortness of breath disappearance and hospital stay in the study group were shorter than those in the control group (P<0.05). The total effective rate of the study group was higher than that of the control group (P<0.05). The levels of TNF-α and IL-1β in the two groups before treatment were compared (P>0.05), and the levels of TNF-α and IL-1β in the two groups were decreased after treatment, and the levels in the study group were lower than those in the control group (P<0.05). The levels of FVC, FEV1 and FEV1/FVC in both groups before treatment (P>0.05), and the levels of FVC, FEV1 and FEV1/FVC in both groups were improved after treatment, and the study group was higher than the control group (P<0.05). Conclusion The combined treatment of azithromycin and propoxyguanyside aerosol inhalation in children with bronchopneumonia has definite curative effect, can significantly shorten the improvement time of clinical symptoms, reduce the inflammatory reaction of the body, improve lung function, and is worthy of clinical use.

Key words: azithromycin, propoxyguanosine, bronchial pneumonia in children, efficacy, inflammatory factor

中图分类号: